Naked Brand (NAKD) 10-Q 14 Jun 17 2018 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Apr. 30, 2017	Jun. 14, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Apr. 30, 2017
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q1
Entity Registrant Name	NAKED BRAND GROUP INC.
Entity Central Index Key	1,383,097
Current Fiscal Year End Date	--01-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	NAKD
Entity Common Stock, Shares Outstanding		10,342,191

Interim Condensed Consolidated

Interim Condensed Consolidated Balance Sheets	Apr. 30, 2017USD ($)	Jan. 31, 2017USD ($)
Current assets
Cash	$ 3,994,925	$ 879,014
Inventory, net of allowances of $375,784 (January 31, 2017: $375,784)	2,371,373	2,228,813
Related party advances receivable	143,613	0
Prepaid expenses and deposits	225,217	496,721
Total current assets	6,735,128	3,604,548
Intangible assets, net	80,875	80,875
TOTAL ASSETS	6,816,003	3,685,423
Current liabilities
Accounts payable and accrued liabilities	693,515	1,761,367
Interest payable	13,463	7,279
Factored line of credit	71,410	302,776
Promissory notes payable	256,450	256,450
Total current liabilities	1,034,838	2,327,872
Deferred compensation	3,704	37,037
TOTAL LIABILITIES	1,038,542	2,364,909
STOCKHOLDERS' EQUITY
Common stock Authorized 2,000,000 shares of blank check preferred stock, no par value 18,000,000 shares of common stock, par value $0.001 per share Issued and outstanding 10,342,191 shares of common stock (January 31, 2017: 6,560,964)	10,342	6,561
Common stock to be issued	14,141	1,670,003
Accumulated paid-in capital	66,126,858	56,829,778
Accumulated deficit	(60,367,635)	(57,179,583)
Accumulated other comprehensive loss	(6,245)	(6,245)
Total stockholders' equity	5,777,461	1,320,514
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 6,816,003	$ 3,685,423

Interim Condensed Consolidated3

Interim Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Apr. 30, 2017	Jan. 31, 2017
Inventory Adjustments, Total	$ 375,784	$ 375,784
Preferred Stock, Shares Authorized	2,000,000	2,000,000
Common Stock, Shares Authorized	18,000,000	18,000,000
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares, Issued	10,342,191	6,560,964
Common Stock, Shares, Outstanding	10,342,191	6,560,964

Interim Condensed Consolidated4

Interim Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Net sales	$ 455,160	$ 447,627
Cost of sales	354,141	307,869
Gross profit	101,019	139,758
Operating Expenses
General and administrative expenses	3,262,663	2,654,621
Foreign exchange	763	(648)
Total operating expenses	3,263,426	2,653,973
Operating loss	(3,162,407)	(2,514,215)
Interest expense	25,414	19,116
Accretion of debt discounts and finance charges	231	6,764
Total other expense	25,645	25,880
Net loss	$ (3,188,052)	$ (2,540,095)
Net loss per share
Basic	$ (0.35)	$ (0.42)
Diluted	$ (0.35)	$ (0.42)
Weighted average shares outstanding
Basic	9,240,272	6,072,482
Diluted	9,240,272	6,072,482

Interim Condensed Consolidated5

Interim Condensed Consolidated Statement of Changes in Stockholders’ Equity - USD ($)	Total	Common Stock [Member]	Accumulated Paid-In Capital [Member]	Common Stock To Be Issued [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Beginning Balance at Jan. 31, 2016	$ 4,587,086	$ 6,070	$ 50,953,341	$ 15,000	$ (46,381,080)	$ (6,245)
Beginning Balance (in shares) at Jan. 31, 2016		6,069,982
Shares issued in a public offering	1,955,003	$ 288	299,712	1,655,003
Shares issued in a public offering (in shares)		288,462
Stock based compensation	5,348,647	$ 0	5,348,647	0	0	0
Net loss for the period	(10,798,503)	0	0	0	(10,798,503)	0
Shares issued pursuant to the conversion of debt	228,281	$ 203	228,078	0
Shares issued pursuant to the conversion of debt (in shares)		202,520
Ending Balance at Jan. 31, 2017	1,320,514	$ 6,561	56,829,778	1,670,003	(57,179,583)	(6,245)
Ending Balance (in shares) at Jan. 31, 2017		6,560,964
Shares issued in a public offering	0	$ 1,592	1,654,270	(1,655,862)	0	0
Shares issued in a public offering (in shares)		1,592,175
Shares issued in an at-the-market offering	5,499,723	$ 2,189	5,497,534	0	0	0
Shares issued in an at-the-market offering (in shares)		2,189,052
less; commission	(192,490)	$ 0	(192,490)	0	0	0
Conversion of accrued salary compensation	654,637	0	654,637	0	0	0
Stock based compensation	1,683,129	0	1,683,129	0	0	0
Net loss for the period	(3,188,052)	0	0	0	(3,188,052)	0
Ending Balance at Apr. 30, 2017	$ 5,777,461	$ 10,342	$ 66,126,858	$ 14,141	$ (60,367,635)	$ (6,245)
Ending Balance (in shares) at Apr. 30, 2017		10,342,191

Interim Condensed Consolidated6

Interim Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Cash flows from operating activities
Net loss	$ (3,188,052)	$ (2,540,095)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts	0	1,140
Provision for obsolete inventory	0	(15,000)
Depreciation and amortization	0	3,207
Stock based compensation	1,683,129	1,143,238
Amortization of deferred financing costs	0	6,764
Changes in operating assets and liabilities:
Related party advances receivable	(143,613)	(10,490)
Prepaid expenses and deposits	271,504	868,768
Inventory	(142,560)	(837,141)
Accounts payable and accrued liabilities	(413,215)	(96,188)
Interest payable	6,184	(98)
Deferred costs	0	(50,000)
Deferred compensation	(33,333)	(33,333)
Net cash used in operating activities	(1,959,956)	(1,559,228)
Cash flows from financing activities
Proceeds from share issuances, net	5,307,233	0
Repayments under factoring arrangements	(231,366)	(308,955)
Net cash provided by (used in) financing activities	5,075,867	(308,955)
Net increase (decrease) in cash	3,115,911	(1,868,183)
Cash at beginning of the period	879,014	4,780,994
Cash at end of the period	3,994,925	2,912,811
Cash paid during the period for:
Interest	0	0
Income Taxes	0	0
Non-cash financing activities:
Extinguishment of accounts payable with equity	$ 654,637	$ 0

Nature of Business

Nature of Business	3 Months Ended
	Apr. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations [Text Block]	1. Nature of Business Naked Brand Group Inc. (the “Company”) is a manufacturer and seller of direct and wholesale men’s and women’s undergarments and intimate apparel within North America to consumers and retailers through its wholly owned subsidiary, Naked Inc. (“Naked”). The Company currently operates out of New York, United States of America. On May 25, 2017, the Company entered into an Agreement and Plan of Reorganization (the “Merger Agreement”), by and among Bendon Limited, a New Zealand limited company (“Bendon”), Bendon Group Holdings Limited, an Australia limited company (“Holdco”), Naked Merger Sub Inc., a Nevada corporation and a wholly owned subsidiary of Holdco (“Merger Sub”), and, solely for the purposes of Sections 2.28 and 5.18(b) of the Merger Agreement, Bendon Investments Ltd., a New Zealand company and the owner of a majority of the outstanding shares of Bendon (the “Principal Shareholder”), pursuant to which Merger Sub will be merged with and into the Company (the “Merger”) with the Company as the surviving corporation. Immediately prior to the consummation of the Merger, Bendon and Holdco will consummate a reorganization (the “Reorganization”), pursuant to which all of the shareholders of Bendon will exchange all the outstanding ordinary shares of Bendon (the “Bendon Ordinary Shares”) for 146,311,063 Upon completion of the Merger, each issued and outstanding share of the Company’s common stock (“Company Common Stock”) will be converted into the right to receive one Holdco Ordinary Share, resulting in the Company’s stockholders owning approximately seven percent ( 7 The completion of the Merger is subject to the satisfaction or waiver of certain customary conditions, including, among others: (i) the accuracy of the other party’s representations and warranties; (ii) performance in all material respects by the other party of its obligations under the Merger Agreement; (iii) the listing of Holdco Ordinary Shares on the Nasdaq Capital Market or the New York Stock Exchange (“NYSE”), subject to official notice of issuance; (iv) the declaration of effectiveness by the SEC of the registration statement on Form F-4 to be filed by Holdco in connection with the transactions (the “Registration Statement”); (v) the Company’s stockholders approving the Merger Agreement and the transactions contemplated thereby at a meeting called for such purposes (the “Stockholder Meeting”); and (vi) other conditions as further described in the Merger Agreement. The Merger Agreement also contains specified termination rights, including the right to terminate the Merger Agreement (i) by mutual agreement of the parties to terminate; (ii) by either party if (1) the Merger has not been consummated by October 30, 2017 (the “Outside Date”), except if the primary reason the Merger has not been consummated is because of the continued review of the Registration Statement by the SEC or the Holdco Ordinary Shares have not been approved for listing on the Nasdaq Capital Market or the NYSE, in which case the Outside Date shall be fifteen (15) days after the later of the completion of the Stockholder Meeting and approval of all regulatory bodies and Nasdaq or the NYSE, (2) any law or order permanently prohibits consummation of the Merger, or (3) the Company’s stockholder approval is not obtained by the Outside Date; (iii) by either party if the other party has breached or failed to perform in any material respect any of its representations and warranties or covenants under the Merger Agreement such that a closing condition is not satisfied (subject to notice and cure and other customary exceptions); and (iv) by the Company if (1) Bendon substantially changes its business as conducted as of the date of the Merger Agreement, or (2) the Company accepts a Superior Proposal (as defined in the Merger Agreement).

Ability to Continue as a Going

Ability to Continue as a Going Concern	3 Months Ended
	Apr. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	2. Ability to Continue as a Going Concern These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) on a going concern basis, which assumes that the Company will continue to realize its assets and discharge its obligations and commitments in the normal course of operations. Realization values may be substantially different from carrying values as shown and these interim condensed consolidated financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. As of April 30, 2017, the Company had not yet achieved profitable operations, had incurred a net loss of $ 3,188,052 60,367,635

Basis of Presentation

Basis of Presentation	3 Months Ended
	Apr. 30, 2017
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies [Text Block]	3. Basis of Presentation The accompanying unaudited condensed consolidated interim financial statements have been prepared by management, without audit, in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, certain information and footnote disclosures normally included in the annual consolidated financial statements in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the disclosures are adequate to make the information presented not misleading and the accompanying financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for fair presentation of statement of financial position, results of operations and cash flows for the interim periods presented. Operating results for the three months ended April 30, 2017 are not necessarily indicative of the results that may be expected for the year ending January 31, 2018. The interim condensed consolidated balance sheet at January 31, 2017 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by GAAP. These unaudited condensed consolidated interim financial statements should be read in conjunction with the most recent audited financial statements of the Company included in its Annual Report on Form 10-K for the year ended January 31, 2017. The Company used several factors in identifying and analyzing reportable segments, including the basis of organization, such as differences in products and services, and geographical areas. The Company’s chief operating decision makers review financial information presented on a consolidated basis for the purposes of making operating decisions and assessing financing performance. The Company has determined that as of April 30, 2017, there is only a single reportable operating segment. The Company operates in one industry, the manufacture and sale of direct and wholesale undergarments. At April 30, 2017 and January 31, 2017, the net book value of substantially all long-lived assets were located in the United States. Three months ended April 30, 2017 2016 Numerator Net loss $ (3,188,052) $ (2,540,095) Denominator Weighted average common stock outstanding 9,240,272 6,072,482 Basic and diluted net loss per share $ (0.35) $ (0.42) Anti-dilutive securities not included in diluted loss per share : Warrants outstanding 1,627,010 1,645,198 Options outstanding 3,487,399 2,147,399 Convertible debt - 60,000 5,114,409 3,852,597 In November 2015, the FASB issued Accounting Standards Update No. 2015-17 “ Income Taxes: Balance Sheet Classification of Deferred Taxes (“ASU 2015-17”) In August 2015, the FASB issued ASU No. 2015-15, Presentation of Financial Statements Going Concern (Subtopic 205-40) - Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting Unless otherwise discussed, management believes the impact of recently issued standards, which are not yet effective, will not have a material impact on our consolidated financial statements upon adoption. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities In February 2016, FASB issued ASU No. 2016-02, Leases

Inventory

Inventory	3 Months Ended
	Apr. 30, 2017
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	4. Inventory April 30, 2017 January 31, 2017 Finished goods $ 2,747,157 $ 2,604,597 Less: allowance for obsolete inventory (375,784) (375,784) Total inventory $ 2,371,373 $ 2,228,813 Balances at April 30, 2017 and January 31, 2017 are recorded at historical cost, less amounts for potential declines in value. At April 30, 2017, management has recorded an allowance for obsolescence of $ 375,784 375,784

Intangible Assets

Intangible Assets	3 Months Ended
	Apr. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	5. Intangible Assets April 30, 2017 January 31, Useful life Trade Names/Trademarks $ 80,875 $ 80,875 Indefinite Website 49,512 49,512 2 130,387 130,387 Less: accumulated amortization (49,512) (49,512) $ 80,875 $ 80,875 The Company did not record any amortization expense during the three months ended April 30, 2017 and 2016.

Related Party Transactions and

Related Party Transactions and Balances	3 Months Ended
	Apr. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	6. Related Party Transactions and Balances Related Party Balances At April 30, 2017, included in advances receivable is $ 143,364 At April 30, 2017, included in promissory notes payable is $ 153,000 153,000 At January 31, 2017, included in accounts payable and accrued liabilities is $ 129,186 53,500 Related Party Transactions During the three months ended April 30, 2017, included in general and administrative expenses is $ 38,969 62,213 169 9,113 Effective June 10, 2014, the Company entered into an employment agreement with the Chief Executive Officer and director (the “CEO”) of the Company for a term of three years whereby the CEO was entitled to a base salary of $ 400,000 3,704 37,037 On June 10, 2015, the CEO became eligible to receive her full base salary pursuant to the terms of her employment agreement, however, such base salary was accrued but not paid through February 28, 2017. The CEO had agreed to allow the Company to defer payment of her salary provided such amounts accrued interest at a rate of 3 654,637 638,724 15,913 1,200,000 2.14 418,163 In connection with a Joint Factoring Agreement (Note 7), the CEO executed a guaranty (the “Guaranty”) to personally guarantee performance of the Obligations and also agreed to provide her own brokerage account as security for the Obligations (as defined in Note 7)). Accordingly, in connection with her brokerage account the CEO entered into a brokerage account pledge and security agreement (the “Pledge and Security Agreement”) and securities account control agreement (the “Account Control Agreement”) in favor of Wells Fargo Bank, National Association (“Wells Fargo”). Pursuant to the Pledge and Security Agreement, the CEO agreed to pledge, sell, assign, grant a security interest in and transfer to Wells Fargo all of her rights, title and interest in and to her brokerage account.

Factoring Line of Credit

Factoring Line of Credit	3 Months Ended
	Apr. 30, 2017
Factoring Agreement [Member]
Debt Disclosure [Text Block]	7. Factoring Line of Credit On June 14, 2016, the Company entered into a Joint Factoring Agreement (the “Joint Factoring Agreement”) with Wells Fargo. The Joint Factoring Agreement with Wells Fargo replaced a factoring agreement with Capital Business Credit LLC, which was terminated effective on the same date. Under the terms of the Joint Factoring Agreement, the Company may assign eligible accounts receivable (the “Accounts”) to Wells Fargo in exchange for loans and advances (each such loan or advance, an “Advance”) up to an aggregate amount (the “Borrowing Base”) not to exceed the lesser of (i) $6,000,000 or (ii) the sum of up to 80% of trade receivables deemed eligible by Wells Fargo plus (A) the lesser of up to (x) 50% of the value, calculated at the lower of cost or market, of finished goods, warehoused inventory deemed eligible by Wells Fargo or (y) $500,000, plus (B) the lesser of (x) up to 75% of marketable securities held in a blocked security account, subject to an account control agreement in favor of Wells Fargo (the “Securities Account”); provided, however, that at any time when the market value of the securities held in such Securities Account is below $1,067,000, then the value of such securities for purposes of calculating the Borrowing Base will be $0 or (y) $200,000, less any reserves that Wells Fargo may establish from time to time. In connection with Wells Fargo’s services under the Joint Factoring Agreement, Wells Fargo receives a commission equal to the Factoring Commission Percentage (as defined in the Joint Factoring Agreement) multiplied by the gross invoice amount of each Account purchased, which is charged to the Company’s account on the date a related Advance is made. During the initial term of the Joint Factoring Agreement, Wells Fargo will receive minimum commissions equal to $ 24,000 36,000 50,000 The Company bears the risk of credit loss on the Accounts, except where Wells Fargo provides credit approval in writing on such Account. The Advances will bear interest on the daily net balance of any moneys owed at a rate of LIBOR plus 3%. All obligations under the Joint Factoring Agreement, including the Advances (collectively, the “Obligations”), are payable on demand and may be charged by Wells Fargo to the Company’s account at any time. The Obligations are secured by a continuing security interest in all assets, properties, and rights of the Company, wherever located, whether owned as of the date of the Joint Factoring Agreement or subsequent thereto. The term of the Joint Factoring Agreement is for three years and will automatically renew, unless terminated at any time by Wells Fargo with thirty days’ written notice, or by the Company prior to such renewal, with sixty days’ prior written notice. The Joint Factoring Agreement contains covenants that are customary for agreements of this type. The failure to satisfy covenants under the Joint Factoring Agreement or the occurrence of other specified events that constitute an event of default could result in the termination of the Joint Factoring Agreement and/or the acceleration of the repayment obligations of the Company. The Joint Factoring Agreement contains provisions relating to events of default that are customary for agreements of this type. The Company has accounted for invoices sold to the Wells Fargo under the Joint Factoring Agreement as a sale of financial assets. As such, the accounts receivable are excluded from the balance sheet upon receipt of consideration for such transfer to Wells Fargo. Factor expenses and interest charged to operations during the three months ended April 30, 2017 were $ 17,709 5,829 71,410 302,776

Promissory Notes Payable

Promissory Notes Payable	3 Months Ended
	Apr. 30, 2017
Promissory Note Payable [Member]
Debt Disclosure [Text Block]	8. Promissory Notes Payable April 30, 2017 January 31, 2017 Unsecured promissory notes, accruing interest at a rate of 10% per annum maturing on the earlier of (i) May 7, 2017 or (ii) the date of closing of an equity financing (see (i)) $ 253,000 $ 253,000 Promissory notes, non-interest bearing, repayable upon the Company reporting net income from operations in a single month (see (ii)) 3,450 3,450 256,450 256,450 Less: current portion (256,450) (256,450) $ - $ - (i) During the year ended January 31, 2017, the Company issued promissory notes in the aggregate principal amount of $ 253,000 153,000 May 7, 2017 Subsequent to April 30, 2017, these promissory notes were repaid in full. (ii) On November 7, 2013, the Company issued a promissory note in the principal amount of CDN$ 28,750 24,467 25,000 15 3,670 3,750 3,450 3,750 3,450 3,750

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Apr. 30, 2017
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	9. Stockholders’ Equity Authorized 2,000,000 18,000,000 0.001 Equity Transactions On February 10, 2017, the Company entered into an At The Market Offering Agreement (the “Agreement”) with Maxim Group LLC (“Maxim”), as amended on March 30, 2017, pursuant to which the Company could sell from time to time, up to an aggregate of $ 5,500,000 Under the terms of the Agreement, Maxim was entitled to a commission at a fixed rate of 3.5 During the three months ended April 30, 2017 pursuant to and under the terms of the Agreement, as amended, the Company issued an aggregate of 2,189,052 5,499,723 5,307,233 Stock Options 2014 Stock Option Plan On June 6, 2014, the Company’s board of directors approved a 2014 Long-Term Incentive Plan (the “2014 Plan”), which provides for the grant of stock options, restricted shares, restricted share units and performance stock and units to directors, officers, employees and consultants of the Company. Stockholder approval of the plan was obtained on August 21, 2014. The maximum number of shares of common stock reserved for issue under the plan is 2,750,000 The 2014 Plan is administered by the board of directors, except that it may, in its discretion, delegate such responsibility to a committee of such board. The exercise price will be determined by the board of directors at the time of grant. Stock options may be granted under the 2014 Plan for an exercise period of up to ten years from the date of grant of the option or such lesser periods as may be determined by the board, subject to earlier termination in accordance with the terms of the 2014 Plan. At April 30, 2017, 509,601 509,601 Stock Based Compensation Number Weighted Weighted Average of Options Exercise Price Fair Value Outstanding at February 1, 2016 2,191,274 $ 5.12 $ 7.86 Expired (93,875) $ 5.19 Forfeited (70,000) $ 5.12 Granted 260,000 $ 2.21 $ 1.41 Outstanding at January 31, 2017 2,287,399 $ 4.78 Granted 1,200,000 $ 2.14 $ 0.89 Outstanding at April 30, 2017 3,487,399 $ 3.87 Exercisable at April 30, 2017 3,072,043 $ 3.89 Number Exercise Expiry Number 15,000 10.00 October 9, 2017 15,000 1,250 10.00 February 1, 2018 1,250 3,750 10.00 May 1, 2018 3,750 2,000 10.00 April 1, 2019 2,000 25,000 10.00 July 30, 2022 25,000 1,536,750 5.12 June 6, 2024 1,421,358 25,000 6.00 June 10, 2024 25,000 37,500 5.12 February 3, 2025 25,000 37,500 4.48 February 25, 2025 25,000 6,250 4.80 July 6, 2025 6,250 337,399 4.40 August 18, 2026 212,435 10,000 2.50 February 25, 2026 10,000 100,000 2.50 November 1, 2026 100,000 150,000 2.00 November 1, 2026 - 1,200,000 2.14 March 13, 2021 1,200,000 3,487,399 3,072,043 The aggregate intrinsic value of stock options outstanding is calculated as the difference between the exercise price of the underlying awards and the fair value of the Company’s common stock. At April 30, 2017, the aggregate intrinsic value of stock options outstanding was $Nil and exercisable was $Nil (January 31, 2017: $Nil and $Nil, respectively). During the three months ended April 30, 2017, the Company recognized a total fair value of $ 1,641,781 1,271,361 992,625 2017 2016 Expected term of stock option (years) (1) 2.00 5.00 Expected volatility (2) 76.10 % 67.70 % Stock price at date of issuance $ 2.14 $ 2.50 Risk-free interest rate 1.40 % 1.16 % Dividend yields 0.00 % 0.00 % (1) (2) Share Purchase Warrants Number Exercise Expiry 12,451 $ 10.00 August 10, 2017 3,750 $ 10.00 August 10, 2018 60,001 $ 6.00 April 4, 2019 555,968 $ 6.00 June 10, 2019 155,052 $ 3.00 June 10, 2019 168,883 $ 6.00 July 8, 2019 29,343 $ 3.00 July 8, 2019 24,625 $ 8.00 October 23, 2019 137,180 $ 4.80 December 23, 2020 365,688 $ 4.80 June 15, 2022 36,569 (1) $ 4.80 June 15, 2022 15,000 $ 4.80 July 6, 2022 62,500 $ 5.11 September 1, 2022 1,627,010 (1) These warrants may vest and become exercisable only under certain anti-dilution performance conditions contained in the warrant agreement. During the year ended January 31, 2016, the Company issued an aggregate of 479,757 4.84 4.67 2,239,000 7 158.04 0.00 2.09 41,348 (104,284) Certain of the warrants granted during the year ended January 31, 2016 become exercisable only under certain anti-dilution performance conditions contained in the warrant agreement. The fair value of these warrants at issuance was calculated to be $ 168,500 7 153.00 0.00 2.11 Number of Weighted Average Warrants Exercise Price Outstanding at February 1, 2016 1,645,198 $ 5.27 Expired (18,188) $ 4.00 Outstanding at January 31, 2017 and April 30, 2017 1,627,010 $ 5.29

Customer Concentrations

Customer Concentrations	3 Months Ended
	Apr. 30, 2017
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	10. Customer Concentrations The Company has concentrations in the volumes of business transacted with particular customers. The loss of these customers could have a material adverse effect on the Company’s business. For the three ended April 30, 2017, the Company had concentrations of sales with two customers equal to 20.4 0 0

Commitments

Commitments	3 Months Ended
	Apr. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	11. Commitments i) In accordance with a negotiated agreement, the Company is required to pay royalty fees based on the greater of a pre-determined percentage of certain sales, not to exceed 10% of these net wholesale sales, as defined in such agreements, or a minimum annual amount. The Company may terminate the agreement in the event that the other party fails to perform any of the services required to be performed under the agreement or breaches any of its other covenants or agreements set forth in the agreement. At April 30, 2017, the Company has not made all minimum royalty payments as they have become due and payable under the terms of the agreement, however as at April 30, 2017, the Company has not been provided a notice of default by the other party to the agreement. If the other party provides such notice of default at a later date, this could affect the Company’s ability to sell certain portions of its inventory on hand and on order at April 30, 2017 that are covered under the royalty agreement. The Company is negotiating to settle the matter on terms that are agreeable to both parties. No provision has been made in the accompanying financial statements for any loss that might be incurred if a negotiated settlement is not able to be achieved. The Company is committed to future minimum royalty payments as follows: Year ending January 31, Amount 2018 $ 262,500 2019 350,000 2020 262,500 $ 875,000 ii) Pursuant to a Strategic Consulting and Collaboration Agreement, the Company is committed to pay a monthly cash retainer ranging from $10,000 to $20,000 over the three-year term of the agreement. The Company has negotiated a hold on the monthly cash retainer, effective March 1, 2016 and continuing indefinitely.

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
	Apr. 30, 2017
Accounting Policies [Abstract]
Interim Financial Statements [Policy Text Block]	Interim Financial Statements The accompanying unaudited condensed consolidated interim financial statements have been prepared by management, without audit, in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, certain information and footnote disclosures normally included in the annual consolidated financial statements in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the disclosures are adequate to make the information presented not misleading and the accompanying financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for fair presentation of statement of financial position, results of operations and cash flows for the interim periods presented. Operating results for the three months ended April 30, 2017 are not necessarily indicative of the results that may be expected for the year ending January 31, 2018. The interim condensed consolidated balance sheet at January 31, 2017 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by GAAP. These unaudited condensed consolidated interim financial statements should be read in conjunction with the most recent audited financial statements of the Company included in its Annual Report on Form 10-K for the year ended January 31, 2017.
Segment Reporting, Policy [Policy Text Block]	Segment Reporting The Company used several factors in identifying and analyzing reportable segments, including the basis of organization, such as differences in products and services, and geographical areas. The Company’s chief operating decision makers review financial information presented on a consolidated basis for the purposes of making operating decisions and assessing financing performance. The Company has determined that as of April 30, 2017, there is only a single reportable operating segment. The Company operates in one industry, the manufacture and sale of direct and wholesale undergarments. At April 30, 2017 and January 31, 2017, the net book value of substantially all long-lived assets were located in the United States.
Earnings Per Share, Policy [Policy Text Block]	Loss per share Three months ended April 30, 2017 2016 Numerator Net loss $ (3,188,052) $ (2,540,095) Denominator Weighted average common stock outstanding 9,240,272 6,072,482 Basic and diluted net loss per share $ (0.35) $ (0.42) Anti-dilutive securities not included in diluted loss per share : Warrants outstanding 1,627,010 1,645,198 Options outstanding 3,487,399 2,147,399 Convertible debt - 60,000 5,114,409 3,852,597
Recently Adopted Accounting Pronouncements [Policy Text Block]	Recently Adopted Accounting Pronouncements In November 2015, the FASB issued Accounting Standards Update No. 2015-17 “ Income Taxes: Balance Sheet Classification of Deferred Taxes (“ASU 2015-17”) In August 2015, the FASB issued ASU No. 2015-15, Presentation of Financial Statements Going Concern (Subtopic 205-40) - Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory In March 2016, the FASB issued ASU No. 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting
New Accounting Pronouncements, Policy [Policy Text Block]	New Accounting Pronouncements Unless otherwise discussed, management believes the impact of recently issued standards, which are not yet effective, will not have a material impact on our consolidated financial statements upon adoption. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities In February 2016, FASB issued ASU No. 2016-02, Leases

Basis of Presentation (Tables)

Basis of Presentation (Tables)	3 Months Ended
	Apr. 30, 2017
Accounting Policies [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Net loss per share was determined as follows: Three months ended April 30, 2017 2016 Numerator Net loss $ (3,188,052) $ (2,540,095) Denominator Weighted average common stock outstanding 9,240,272 6,072,482 Basic and diluted net loss per share $ (0.35) $ (0.42) Anti-dilutive securities not included in diluted loss per share : Warrants outstanding 1,627,010 1,645,198 Options outstanding 3,487,399 2,147,399 Convertible debt - 60,000 5,114,409 3,852,597

Inventory (Tables)

Inventory (Tables)	3 Months Ended
	Apr. 30, 2017
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventory of the Company consisted of the following at April 30, 2017 and January 31, 2017: April 30, 2017 January 31, 2017 Finished goods $ 2,747,157 $ 2,604,597 Less: allowance for obsolete inventory (375,784) (375,784) Total inventory $ 2,371,373 $ 2,228,813

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Apr. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	Intangible assets of the Company consisted of the following at April 30, 2017 and January 31, 2016: April 30, 2017 January 31, Useful life Trade Names/Trademarks $ 80,875 $ 80,875 Indefinite Website 49,512 49,512 2 130,387 130,387 Less: accumulated amortization (49,512) (49,512) $ 80,875 $ 80,875

Promissory Notes Payable (Table

Promissory Notes Payable (Tables)	3 Months Ended
	Apr. 30, 2017
Promissory Note Payable [Member]
Schedule of Debt [Table Text Block]	April 30, 2017 January 31, 2017 Unsecured promissory notes, accruing interest at a rate of 10% per annum maturing on the earlier of (i) May 7, 2017 or (ii) the date of closing of an equity financing (see (i)) $ 253,000 $ 253,000 Promissory notes, non-interest bearing, repayable upon the Company reporting net income from operations in a single month (see (ii)) 3,450 3,450 256,450 256,450 Less: current portion (256,450) (256,450) $ - $ - (i) During the year ended January 31, 2017, the Company issued promissory notes in the aggregate principal amount of $ 253,000 153,000 May 7, 2017 Subsequent to April 30, 2017, these promissory notes were repaid in full. (ii) On November 7, 2013, the Company issued a promissory note in the principal amount of CDN$ 28,750 24,467 25,000 15 3,670 3,750 3,450 3,750 3,450 3,750

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Apr. 30, 2017
Stockholders' Equity Note [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of the status of the Company’s outstanding stock options for the periods ended April 30, 2017 and January 31, 2017 is presented below: Number Weighted Weighted Average of Options Exercise Price Fair Value Outstanding at February 1, 2016 2,191,274 $ 5.12 $ 7.86 Expired (93,875) $ 5.19 Forfeited (70,000) $ 5.12 Granted 260,000 $ 2.21 $ 1.41 Outstanding at January 31, 2017 2,287,399 $ 4.78 Granted 1,200,000 $ 2.14 $ 0.89 Outstanding at April 30, 2017 3,487,399 $ 3.87 Exercisable at April 30, 2017 3,072,043 $ 3.89
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	At April 30, 2017, the following stock options were outstanding, entitling the holder thereof to purchase shares of common stock of the Company as follows: Number Exercise Expiry Number 15,000 10.00 October 9, 2017 15,000 1,250 10.00 February 1, 2018 1,250 3,750 10.00 May 1, 2018 3,750 2,000 10.00 April 1, 2019 2,000 25,000 10.00 July 30, 2022 25,000 1,536,750 5.12 June 6, 2024 1,421,358 25,000 6.00 June 10, 2024 25,000 37,500 5.12 February 3, 2025 25,000 37,500 4.48 February 25, 2025 25,000 6,250 4.80 July 6, 2025 6,250 337,399 4.40 August 18, 2026 212,435 10,000 2.50 February 25, 2026 10,000 100,000 2.50 November 1, 2026 100,000 150,000 2.00 November 1, 2026 - 1,200,000 2.14 March 13, 2021 1,200,000 3,487,399 3,072,043
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The fair value of each option award was estimated on the date of the grant using the Black-Scholes option pricing model based on the following weighted average assumptions: 2017 2016 Expected term of stock option (years) (1) 2.00 5.00 Expected volatility (2) 76.10 % 67.70 % Stock price at date of issuance $ 2.14 $ 2.50 Risk-free interest rate 1.40 % 1.16 % Dividend yields 0.00 % 0.00 % (1) (2)
Schedule Of Share Based Compensation Shares Authorized Under Warrants By Exercise Price Range [Table Text Block]	At April 30, 2017, the Company had 1,627,010 share purchase warrants outstanding as follows: Number Exercise Expiry 12,451 $ 10.00 August 10, 2017 3,750 $ 10.00 August 10, 2018 60,001 $ 6.00 April 4, 2019 555,968 $ 6.00 June 10, 2019 155,052 $ 3.00 June 10, 2019 168,883 $ 6.00 July 8, 2019 29,343 $ 3.00 July 8, 2019 24,625 $ 8.00 October 23, 2019 137,180 $ 4.80 December 23, 2020 365,688 $ 4.80 June 15, 2022 36,569 (1) $ 4.80 June 15, 2022 15,000 $ 4.80 July 6, 2022 62,500 $ 5.11 September 1, 2022 1,627,010 (1) These warrants may vest and become exercisable only under certain anti-dilution performance conditions contained in the warrant agreement.
Schedule of Share Purchase Warrants Activity [Table Text Block]	Number of Weighted Average Warrants Exercise Price Outstanding at February 1, 2016 1,645,198 $ 5.27 Expired (18,188) $ 4.00 Outstanding at January 31, 2017 and April 30, 2017 1,627,010 $ 5.29

Commitments (Tables)

Commitments (Tables)	3 Months Ended
	Apr. 30, 2017
Royalty Agreements [Member]
Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block]	The Company is committed to future minimum royalty payments as follows: Year ending January 31, Amount 2018 $ 262,500 2019 350,000 2020 262,500 $ 875,000

Nature of Business (Details Tex

Nature of Business (Details Textual)	1 Months Ended
	May 25, 2017shares
HoldCo [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	146,311,063
Subsequent Event [Member] | Bendon Group Holdings Limited [Member]
Noncontrolling Interest, Ownership Percentage by Parent	7.00%

Ability to Continue as a Goin26

Ability to Continue as a Going Concern (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Apr. 30, 2017	Apr. 30, 2016	Jan. 31, 2017
Net loss	$ (3,188,052)	$ (2,540,095)	$ (10,798,503)
Retained Earnings (Accumulated Deficit)	$ (60,367,635)		$ (57,179,583)

Basis of Presentation (Details)

Basis of Presentation (Details) - USD ($)	3 Months Ended		12 Months Ended
	Apr. 30, 2017	Apr. 30, 2016	Jan. 31, 2017
Numerator
Net loss	$ (3,188,052)	$ (2,540,095)	$ (10,798,503)
Denominator
Weighted average common stock outstanding	9,240,272	6,072,482
Basic and diluted net loss per share	$ (0.35)	$ (0.42)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	5,114,409	3,852,597
Convertible debt [Member]
Denominator
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	60,000
Warrant [Member]
Denominator
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,627,010	1,645,198
Employee Stock Option [Member]
Denominator
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,487,399	2,147,399

Inventory (Details)

Inventory (Details) - USD ($)	Apr. 30, 2017	Jan. 31, 2017
Inventory [Line Items]
Finished goods	$ 2,747,157	$ 2,604,597
Less: allowance for obsolete inventory	(375,784)	(375,784)
Total inventory	$ 2,371,373	$ 2,228,813

Inventory (Details Textual)

Inventory (Details Textual) - USD ($)	Apr. 30, 2017	Jan. 31, 2017
Inventory [Line Items]
Inventory Adjustments, Total	$ 375,784	$ 375,784

Intangible Assets (Details)

Intangible Assets (Details) - USD ($)	3 Months Ended
	Apr. 30, 2017	Jan. 31, 2017
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 130,387	$ 130,387
Less: accumulated amortization	(49,512)	(49,512)
Intangible Assets, Net (Excluding Goodwill)	80,875	80,875
Website [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 49,512	49,512
Finite-Lived Intangible Asset, Useful Life	2 years
Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	$ 80,875	$ 80,875

Intangible Assets (Details Text

Intangible Assets (Details Textual) - USD ($)	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Intangible Assets [Line Items]
Amortization of Intangible Assets	$ 0	$ 0

Related Party Transactions an32

Related Party Transactions and Balances (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Apr. 30, 2017	Apr. 30, 2016	Jan. 31, 2017
Related Party Transaction [Line Items]
Share-based Compensation, Total	$ 1,683,129	$ 1,143,238
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,200,000		260,000
Deferred Compensation Liability, Classified, Noncurrent	$ 3,704		$ 37,037
Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage	3.00%
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 2.14		$ 2.21
Cost of Reimbursable Expense			$ 53,500
Due from Related Parties, Current	$ 143,613		0
Directors And Officers [Member]
Related Party Transaction [Line Items]
Convertible Notes Payable, Current	153,000		153,000
Directors And Officers [Member] | General and Administrative Expense [Member]
Related Party Transaction [Line Items]
Noninterest Expense Directors Fees	38,969	62,213
Other Related Party [Member] | General and Administrative Expense [Member]
Related Party Transaction [Line Items]
Marketing Expense	169	$ 9,113
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Share-based Compensation, Total	418,163
Chief Executive Officer [Member] | Employement Agreement [Member]
Related Party Transaction [Line Items]
Officers' Compensation	$ 400,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,200,000
Deferred Compensation Liability, Classified, Noncurrent	$ 3,704		37,037
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 2.14
Accrued Salaries And Interest Payable	$ 654,637
Accrued Salaries	638,724
Interest Payable	$ 15,913
Chief Executive Officer [Member] | Employement Agreement [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	4 years
Chief Executive Officer [Member] | Employement Agreement [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Accounts Payable and Accrued Liabilities [Member]
Related Party Transaction [Line Items]
Due to Officers or Stockholders, Current			$ 129,186

Factoring Line of Credit (Detai

Factoring Line of Credit (Details Textual) - USD ($)	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016	Jan. 31, 2017	Jun. 14, 2016
Factoring Line of Credit [Line Items]
Interest Expense, Debt	$ 17,709	$ 5,829
Line of Credit, Current	$ 71,410		$ 302,776
First Year [Member]
Factoring Line of Credit [Line Items]
Debt Instrument, Fee Amount				$ 24,000
Second Year [Member]
Factoring Line of Credit [Line Items]
Debt Instrument, Fee Amount				36,000
Third Year [Member]
Factoring Line of Credit [Line Items]
Debt Instrument, Fee Amount				$ 50,000
Wells Fargo Bank [Member]
Factoring Line of Credit [Line Items]
Debt Instrument, Interest Rate, Basis for Effective Rate	LIBOR plus 3%
Debt Instrument, Description	Under the terms of the Joint Factoring Agreement, the Company may assign eligible accounts receivable (the “Accounts”) to Wells Fargo in exchange for loans and advances (each such loan or advance, an “Advance”) up to an aggregate amount (the “Borrowing Base”) not to exceed the lesser of (i) $6,000,000 or (ii) the sum of up to 80% of trade receivables deemed eligible by Wells Fargo plus (A) the lesser of up to (x) 50% of the value, calculated at the lower of cost or market, of finished goods, warehoused inventory deemed eligible by Wells Fargo or (y) $500,000, plus (B) the lesser of (x) up to 75% of marketable securities held in a blocked security account, subject to an account control agreement in favor of Wells Fargo (the “Securities Account”); provided, however, that at any time when the market value of the securities held in such Securities Account is below $1,067,000, then the value of such securities for purposes of calculating the Borrowing Base will be $0 or (y) $200,000, less any reserves that Wells Fargo may establish from time to time.

Promissory Notes Payable (Detai

Promissory Notes Payable (Details)		Apr. 30, 2017USD ($)	Jan. 31, 2017USD ($)	Jan. 31, 2017CAD	Jan. 31, 2016USD ($)	Jan. 31, 2016CAD
Notes Payable		$ 256,450	$ 256,450
Less: current portion		256,450	256,450	CAD 3,750	$ 3,450	CAD 3,750
Notes Payable, Noncurrent		0	0
Unsecured promissory notes [Member]
Notes Payable	[1]	253,000	253,000
Promissory notes, non-interest bearing [Member]
Notes Payable	[2]	$ 3,450	$ 3,450
[1]	During the year ended January 31, 2017, the Company issued promissory notes in the aggregate principal amount of $253,000 in exchange for cash, including an amount of $153,000 to a director and officer of the Company. The promissory notes accrue interest at the rate of ten percent per annum and mature on the earlier to occur of (i) May 7, 2017 or (ii) the date of the closing date of an Equity Financing (as defined in the promissory note). Subsequent to April 30, 2017, these promissory notes were repaid in full.
[2]	On November 7, 2013, the Company issued a promissory note in the principal amount of CDN$28,750. The Company received $24,467 (CDN$25,000) in respect of this note, after an original issue discount (“OID”) of 15%, or $3,670 (CDN$3,750). The principal amount, net of the OID, matured and was repaid during the year ended January 31, 2015. At January 31, 2017, an amount of $3,450 (CDN$3,750) (2016: $3,450 (CDN$3,750)) is outstanding relating to the OID, which is repayable upon the Company reporting net income from operations in any single month.

Promissory Notes Payable (Det35

Promissory Notes Payable (Details Textual)	Nov. 07, 2013USD ($)	Nov. 07, 2013CAD	Jan. 31, 2017USD ($)	Apr. 30, 2017USD ($)	Jan. 31, 2017CAD	Jan. 31, 2016USD ($)	Jan. 31, 2016CAD	Nov. 07, 2013CAD
Promissory Note Payable [Line Items]
Debt Instrument, Discount Price, Percentage	15.00%	15.00%
Debt Instrument, Face Amount | CAD								CAD 28,750
Proceeds from Notes Payable	$ 24,467	CAD 25,000
Debt Instrument, Unamortized Discount	$ 3,670							CAD 3,750
Notes Payable, Current, Total			$ 256,450	$ 256,450	CAD 3,750	$ 3,450	CAD 3,750
Commercial Paper [Member]
Promissory Note Payable [Line Items]
Proceeds from Notes Payable			$ 253,000
Debt Instrument, Maturity Date			May 7, 2017
Commercial Paper [Member] | Director [Member]
Promissory Note Payable [Line Items]
Proceeds from Notes Payable			$ 153,000

Stockholders' Equity (Details)

Stockholders' Equity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Apr. 30, 2017	Jan. 31, 2017
Number of Option, Beginning Balance	2,287,399	2,191,274
Number of Option, Expired		(93,875)
Number of Option, Forfeited		(70,000)
Number of Option, Granted	1,200,000	260,000
Number of Option, Ending Balance	3,487,399	2,287,399
Number of Option, Exercisable	3,072,043
Weighted Average Exercise Price, Beginning Balance	$ 4.78	$ 5.12
Weighted Average Exercise Price, Expired		5.19
Weighted Average Exercise Price, Forfeited		5.12
Weighted Average Exercise Price, Granted	2.14	2.21
Weighted Average Exercise Price, Ending Balance	3.87	4.78
Weighted Average Exercise Price, Exercisable	3.89
Weighted Average Grant Date Fair Value, Beginning Balance	1.41	7.86
Weighted Average Grant Date Fair Value, Ending Balance		$ 1.41
Weighted Average Grant Date Fair Value, Granted	$ 0.89

Stockholders' Equity (Details 1

Stockholders' Equity (Details 1)	3 Months Ended
	Apr. 30, 2017$ / sharesshares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	3,487,399
Number Vested	3,072,043
Excercise Price Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	15,000
Exercise Price | $ / shares	$ 10
Expiry Date	Oct. 9, 2017
Number Vested	15,000
Excercise Price Range Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	1,250
Exercise Price | $ / shares	$ 10
Expiry Date	Feb. 1, 2018
Number Vested	1,250
Excercise Price Range Three [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	3,750
Exercise Price | $ / shares	$ 10
Expiry Date	May 1, 2018
Number Vested	3,750
Excercise Price Range Four [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	2,000
Exercise Price | $ / shares	$ 10
Expiry Date	Apr. 1, 2019
Number Vested	2,000
Excercise Price Range Five [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	25,000
Exercise Price | $ / shares	$ 10
Expiry Date	Jul. 30, 2022
Number Vested	25,000
Excercise Price Range Six [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	1,536,750
Exercise Price | $ / shares	$ 5.12
Expiry Date	Jun. 6, 2024
Number Vested	1,421,358
Excercise Price Range Seven [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	25,000
Exercise Price | $ / shares	$ 6
Expiry Date	Jun. 10, 2024
Number Vested	25,000
Excercise Price Range Eight [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	37,500
Exercise Price | $ / shares	$ 5.12
Expiry Date	Feb. 3, 2025
Number Vested	25,000
Excercise Price Range Nine [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	37,500
Exercise Price | $ / shares	$ 4.48
Expiry Date	Feb. 25, 2025
Number Vested	25,000
Excercise Price Range Ten [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	6,250
Exercise Price | $ / shares	$ 4.80
Expiry Date	Jul. 6, 2025
Number Vested	6,250
Excercise Price Range Eleven [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	337,399
Exercise Price | $ / shares	$ 4.40
Expiry Date	Aug. 18, 2026
Number Vested	212,435
Excercise Price Range Twelve [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	10,000
Exercise Price | $ / shares	$ 2.50
Expiry Date	Feb. 25, 2026
Number Vested	10,000
Excercise Price Range Thirteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	100,000
Exercise Price | $ / shares	$ 2.50
Expiry Date	Nov. 1, 2026
Number Vested	100,000
Excercise Price Range Fourteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	150,000
Exercise Price | $ / shares	$ 2
Expiry Date	Nov. 1, 2026
Number Vested	0
Excercise Price Range Fifteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number	1,200,000
Exercise Price | $ / shares	$ 2.14
Expiry Date	Mar. 13, 2021
Number Vested	1,200,000

Stockholders' Equity (Details 2

Stockholders' Equity (Details 2) - Employee Stock Option [Member] - $ / shares		3 Months Ended
		Apr. 30, 2017	Apr. 30, 2016
Expected term of stock option (years)	[1]	2 years	5 years
Expected volatility	[2]	76.10%	67.70%
Stock price at date of issuance		$ 2.14	$ 2.50
Risk-free interest rate		1.40%	1.16%
Dividend yields		0.00%	0.00%
[1]	As the Company has insufficient historical data on which to estimate the expected term of the options, the Company has elected to apply the short-cut method to determine the expected term under the guidance of Staff Accounting Bulletin No. 110.
[2]	As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company has estimated expected share price volatility based on the historical share price volatility of comparable entities.

Stockholders' Equity (Details 3

Stockholders' Equity (Details 3)	3 Months Ended
	Apr. 30, 2017$ / sharesshares
Number	1,627,010
Share Purchase Warrants Exercise Range One [Member]
Number	12,451
Exercise Price | $ / shares	$ 10
Expiry Date	Aug. 10, 2017
Share purchase Warrants Exercise Range Two [Member]
Number	3,750
Exercise Price | $ / shares	$ 10
Expiry Date	Aug. 10, 2018
Share purchase warrants Exercise Range Three [Member]
Number	60,001
Exercise Price | $ / shares	$ 6
Expiry Date	Apr. 4, 2019
Share Purchase Warrants Exercise Range Four [Member]
Number	555,968
Exercise Price | $ / shares	$ 6
Expiry Date	Jun. 10, 2019
Share Purchase Warrants Exercise Range Five [Member]
Number	155,052
Exercise Price | $ / shares	$ 3
Expiry Date	Jun. 10, 2019
Share Purchase Warrants Exercise Range Six [Member]
Number	168,883
Exercise Price | $ / shares	$ 6
Expiry Date	Jul. 8, 2019
Share Purchase Warrants Exercise Range Seven [Member]
Number	29,343
Exercise Price | $ / shares	$ 3
Expiry Date	Jul. 8, 2019
Share Purchase Warrants Exercise Range Eight [Member]
Number	24,625
Exercise Price | $ / shares	$ 8
Expiry Date	Oct. 23, 2019
Share Purchase Warrants Exercise Range Nine [Member]
Number	137,180
Exercise Price | $ / shares	$ 4.80
Expiry Date	Dec. 23, 2020
Share Purchase Warrants Exercise Range Ten [Member]
Number	365,688
Exercise Price | $ / shares	$ 4.80
Expiry Date	Jun. 15, 2022
Share Purchase Warrants Exercise Range Eleven [Member]
Number	36,569	[1]
Exercise Price | $ / shares	$ 4.80
Expiry Date	Jun. 15, 2022
Share Purchase Warrants Exercise Range Twelve [Member]
Number	15,000
Exercise Price | $ / shares	$ 4.80
Expiry Date	Jul. 6, 2022
Share Purchase Warrants Exercise Range Thirteen [Member]
Number	62,500
Exercise Price | $ / shares	$ 5.11
Expiry Date	Sep. 1, 2022
[1]	These warrants may vest and become exercisable only under certain anti-dilution performance conditions contained in the warrant agreement.

Stockholders' Equity (Details 4

Stockholders' Equity (Details 4) - Warrant [Member]	12 Months Ended
	Jan. 31, 2017$ / sharesshares
Number of Warrants Outstanding, Beginning Balance | shares	1,645,198
Number of Warrants, Expired | shares	(18,188)
Number of Warrants Outstanding, Ending Balance | shares	1,627,010
Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 5.27
Weighted Average Exercise Price, Expired | $ / shares	4
Weighted Average Exercise Price, Ending Balance | $ / shares	$ 5.29

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	Feb. 10, 2017	Apr. 30, 2017	Apr. 30, 2016	Jan. 31, 2017	Jan. 31, 2016	Jun. 06, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred Stock, Shares Authorized		2,000,000		2,000,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total		$ 992,625
Share-based Compensation, Total		1,683,129	$ 1,143,238
Stock Issued During Period, Value, New Issues		$ 0		$ 1,955,003
Common Stock, Par or Stated Value Per Share		$ 0.001		$ 0.001
Proceeds from Issuance of Common Stock		$ 5,307,233	0
Common Stock, Shares Authorized		18,000,000		18,000,000
Maxim Group LLC [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Underwriter Commssion Fee Percentage	3.50%
At The Market Offering [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues		2,189,052
Stock Issued During Period, Value, New Issues		$ 5,499,723
At-The-Market Offering, Maximum Number Of Shares Authorized	5,500,000
Proceeds from Issuance of Common Stock		$ 5,307,233
Long-Term Incentive Plan 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance						2,750,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		509,601		509,601
Anti-Dilution Performance Conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term					7 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate					153.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate					0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate					2.11%
Share-Based Compensation Arrangement By ShareBased Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value Amount					$ 168,500
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period					479,757
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 4.84
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms					7 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 4.67
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate					158.04%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate					0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate					2.09%
Share-based Compensation, Total		$ 41,348	$ (104,284)
Share-Based Compensation Arrangement By ShareBased Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value Amount					$ 2,239,000

Customer Concentrations (Detail

Customer Concentrations (Details Textual) - Two Customers Concentration Risk [Member] - USD ($)	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016	Jan. 31, 2017
Concentration Risk [Line Items]
Concentration Risk, Percentage		32.20%
Accounts Receivable, Net, Current	$ 0		$ 0
Sales Revenue, Net [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	20.40%

Commitments (Details)

Commitments (Details) - Royalty Agreements [Member]	Jan. 31, 2017USD ($)
2,018	$ 262,500
2,019	350,000
2,020	262,500
Contractual Obligation, Total	$ 875,000

Commitments (Details Textual)

Commitments (Details Textual)	3 Months Ended
	Apr. 30, 2017USD ($)
Royalty Expense Percentage	10.00%
Strategic Consulting and Collaboration Agreement [Member] | Minimum [Member]
Retainage Deposit	$ 10,000
Strategic Consulting and Collaboration Agreement [Member] | Maximum [Member]
Retainage Deposit	$ 20,000